Jump to: Abstract | Full Text | Plain Language Summary | Infographic | Conclusions | References [caption id="attachment_10551" align="alignright" width="225"] click on the image to open high resolution version of the infographic[/caption] Plain Language Summary Should I take...
Dormuth CR, Kim JD, Fisher A, Piszczek J, Kuo IF. Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications. JAMA Network Open. 2023; 6(10):e2336678. DOI: 10.1001/jamanetworkopen.2023.36678 Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization...
Nirmatrelvir and ritonavir (NMV-r; PaxlovidTM) is an oral antiviral drug combination that targets a key SARS-CoV-2 protease enzyme. It was approved by Health Canada on January 17, 2022 for treatment of mild-to-moderate Covid-19 disease in...